Home
>
National Drug Code (NDC)
>
Lodosyn
Lodosyn - 25010-711-15 - (carbidopa)
Drug Information of Lodosyn
| Product NDC: | 25010-711 |
| Proprietary Name: | Lodosyn |
| Non Proprietary Name: | carbidopa |
| Active Ingredient(s): | 25 mg/1 & nbsp; carbidopa |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lodosyn
| Product NDC: | 25010-711 |
| Labeler Name: | Aton Pharma, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017830 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090601 |
Package Information of Lodosyn
| Package NDC: | 25010-711-15 |
| Package Description: | 100 TABLET in 1 BOTTLE (25010-711-15) |
NDC Information of Lodosyn
| NDC Code | 25010-711-15 |
| Proprietary Name | Lodosyn |
| Package Description | 100 TABLET in 1 BOTTLE (25010-711-15) |
| Product NDC | 25010-711 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | carbidopa |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090601 |
| Marketing Category Name | NDA |
| Labeler Name | Aton Pharma, Inc |
| Substance Name | CARBIDOPA |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA] |
